The molecular genetics of human endometrial carcinoma have yet to be defined to any significant extent. Cell lines from 11 endometrial carcinomas were examined for alterations in proto-oncogenes that might predictably be present, based on existing data from the better-characterized human carcinomas
Oncogene alterations in endometrial carcinoma
β Scribed by Matthew P. Borst; Vicki V. Baker; Diane Dixon; Kenneth D. Hatch; Hugh M. Shingleton; Donald M. Miller
- Book ID
- 119053474
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 417 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The fhit (fragile histidine triad) gene on chromosome 3p14.2 is a candidate tumour-suppressor gene; its abnormal transcripts are detected in several human cancers. To define the role of the fhit gene in the development of endometrial cancer, we examined 39 endometrial carcinomas for the presence of
## Abstract The present study was undertaken to define the gene(s) of importance on the long arm of chromosome 18 (chromosome 18q) in endometrial carcinomas. We analyzed loss of heterozygosity (LOH) at 3 loci on chromosome 18q and DCC gene expression by the reverseβtranscriptase/polymerase chain re